Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning

This publication has 21 references indexed in Scilit:

• Dosing in phase II trial of Alzheimer's vaccine suspended.
  The Lancet Neurology, 2002
• Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
  Nature, 2000
• Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
  Nature, 1999
• Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice
  Nature Medicine, 1997
• Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo
  Neuron, 1996
• Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
  Nature Medicine, 1996
• REVIEWThe Gene Defects Responsible for Familial Alzheimer's Disease
  Neurobiology of Disease, 1996
• New Insights into the Genetics of Alzheimer's Disease
  Annals of Medicine, 1996
• An Increased Percentage of Long Amyloid β Protein Secreted by Familial Amyloid β Protein Precursor (βApp ₇₁₇ ) Mutants
  Science, 1994
• Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production
  Nature, 1992